Living with an Induced Menopause
|
|
- Dominic Rose
- 6 years ago
- Views:
Transcription
1 Living with an Induced Menopause Dr Jenifer Sassarini Clinical Lecturer Obstetrics and Gynaecology University of Glasgow 2 February 2017
2 70% of women in UK living with breast cancer have hot flushes 1/3 >69 years are still symptomatic
3 What are menopausal symptoms? 1. Vasomotor symptoms: hot flushes night sweats 2. Vulvo-vaginal dryness 3. Sleep disturbance 4. Mood disturbance 5. Sexual dysfunction NIH State-of-the-Science Panel. Ann Intern Med 2005
4 Why do breast cancer patients get menopausal symptoms? Young women after chemotherapy or oophorectomy Peri and postmenopausal women who stop taking HRT Pre and postmenopausal women taking endocrine therapy for 5-10 years Vasomotor symptoms are more frequent and severe after breast cancer compared to natural menopause ovaginal dryness particularly severe with aromatase inhibitors oatac: Vaginal dryness; Anastrozole 18.5% Tamoxifem 9.1% Dyspareunia; 17.3% 8.1% Hickey et al 2008, Kemp et al 2014, Marino et al 2014, Howell et al 2005, ACOG 2014
5 Why are menopausal symptoms after breast cancer problematic? 1. May lead to discontinuation of endocrine therapy Up to 50% stop due to hot flushes, which may lead to 20% increase in mortality Howard-Anderson et al 2012, Chen et al 2013, Makubate et al 2013
6 The value of high adherence to tamoxifen in women with breast cancer: a communitybased cohort study C McCowan, S Wang, A M Thompson, B Makubate and D J Petrie Br J Cancer Sep 3;109(5): All women with incident breast cancer between 1993 and 2000 who were prescribed tamoxifen in the Tayside region of Scotland. 475 (38%) patients had low adherence, which was associated with reduced time to recurrence of 52% (P<0.001). Time to other cause mortality was also reduced by 23% (P <0.055) but this was not statistically significant.
7 Low adherence could cause a 20% Increase in Breast Cancer Mortality " We reported on 576 women classed as having low adherence with 266 dying (46%). High adherence had 2785 with 928 dying (33%). That gives a crude difference in deaths of 13% between the two groups (page 1518). The hazard ratio between the groups was this actually means that women with low adherence have a 20% increased risk of death at any given point of time compared to women with high adherence." C. McCowan Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Makubate et al. BJC (2013) 108,
8 Why are menopausal symptoms after breast cancer problematic? 2. May have implications for prognosis? Indicate better prognosis in breast cancer Howard-Anderson et al 2012, Chen et al 2013, Makubate et al 2013
9 Figure 1. Hot flashes in association with breast cancer recurrence, SBCSS. Chen Y, Dorjgochoo T, Bao PP, Zheng Y, Cai H, et al. (2013) Menopausal Symptoms among Breast Cancer Patients: A Potential Indicator of Favorable Prognosis. PLOS ONE 8(9): e doi: /journal.pone
10 3. May impair quality of life: Why are menopausal symptoms after breast cancer problematic? Worse than the cancer treatment for some women 4. May exacerbate common post-cancer problems such as sleep disturbance and fatigue 5. Risks of early menopause may contribute to morbidity and mortality: Osteoporosis and cardiovascular disease Howard-Anderson et al 2012, Chen et al 2013, Makubate et al 2013
11
12 What works for vasomotor symptoms?
13 Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes Cochrane Database of Systematic Reviews 18 OCT 2004 DOI: / CD pub2
14 Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes Cochrane Database of Systematic Reviews 18 OCT 2004 DOI: / CD pub2
15 HRT may increase the risk of breast cancer recurrence or new breast cancer HR 2.4 HABITS Study Group Holmberg et al 2008
16 Tibolone: increased risk of recurrence and new breast cancer Kenemans et al, Lancet Oncol 2009
17 What else do we have for vasomotor symptoms? Clonidine mcg increasing to 50mcg bd Better than placebo but less effective than SSRI / SNRI / gabapentin Side effects limit tolerability Dry mouth, dizzy, constipation Licenced for VMS Boekhout A H et al. JCO 2011
18 Loprinzi et al 2000, 2002,Stearns et al 2005, Evans et al 2006, Speroff et al 2008, Pinkerton et Al Simon et al 2013, Freeman et al 2012, Carpenter et al 2012, Ensrud et al 2012, Carpenter et al, 2012, La Croix et al 2012, Reed et al 2012, Suvanto-Luukkonen et al 2005, Guthrie et al 2015 What works for vasomotor symptoms?: Antidepressants Name Desvenlafaxine 100mg Reduction in hot flashes vs placebo Daily reduction in hot flashes Duration of studies Additional benefits 64% (vs 51%) 12 months Improved sleep Nausea, constipation, sexual dysfunction Venlafaxine 75mg SR 60% (vs 27%) -1.8 compared to -2.4 with ultra low dose estrogen 8 weeks Improved sleep Equivalent to very low dose estrogen. Nausea, constipation, sexual dysfunction Paroxetine 12.5mg 56% (vs 28%) 24 months Nausea, fatigue, dizzyness, insomnia. No discontinuation syndrome at lower doses. No change in sexual function Improved sleep and reduced burden of hot flashes Escitalopram (10-20mg) 55 % (vs 36%) -1.4 compared to -2.4 with ultra low dose estrogen 8 weeks Improved sleep, mood, quality of life and hot flash interference Does not impair sexual function. Citalopram 10mg 49% (vs 23%) 6 weeks Does not impair sexual function. Fluoxetine 20mg 50% (vs 36%) 9 months Nausea, constipation, sexual dysfunction
19 Venlafaxine 75mg equivalent to ultra-low dose estradiol (0.25mg) estradiol for VMS Joffe H et al JAMA Internal Medicine July 2014 Volume 174, Number 7
20 What works for vasomotor symptoms?: Pharmacological treatments Gabapentin (900 mg/day) As effective as ultra low dose estrogen Premarin 0.3mg or 25 estradiol mcg patch Limitations Drowsiness, confusion, ataxia Start at 300mg/day and increase slowly Can be used by women already taking SSRI/SNRI Butt et al 2008 Reddy et al 2006, Aguirre et al 2010, Pinkerton et al 2014
21 What works for vasomotor symptoms? Mind Body therapies Cognitive behaviour therapy Reduced problem rating (but not frequency) of vasomotor symptoms Nearly 80% reported improvements in vasomotor symptoms Side effects Improved mood Reduced anxiety Mann et al, 2012, Ayres et al 2012
22 What works for vulvovaginal symptoms?
23 Managing vulvovaginal atrophy after breast cancer Vaginal estrogens effective but are systemically absorbed Vaginal estradiol (25 mcg) significantly increased systemic E2 in aromatase inhibitor users Current dose is 10 mcg ( vagifem low ) oless systemic absorption oeffect on TAM users unknown Many oncologists avoid vaginal estrogen but clinical implications unknown Kendall et al 2006, Ferrazzi et al 1977, Freidrich et al 1998, Santen RJ 2015
24 Figure 1 Time course of mean estradiol (E2) plasma concentrations during 24 h after vaginal administration of 10 μg E2 tablets on day 1, 1, 14, 82, and 83 of treatment
25 Managing atrophic vaginitis after breast cancer Avoid vaginal estrogens in AI users Consider vaginal estrogens in TAM users Still discuss with oncologist Relative efficacy of vaginal lubricants unknown Silicone based products reduce pain at intercourse more than water based Vulval lignocaine (4%) reduces dyspareunia and sexual distress in breast cancer survivors Goetsch et al J Clin Oncol 2015, Hickey et al, submitted JCO 2016
26 Sexual dysfunction, sleep disturbance, osteoporosis, cardiovascular disease?
27
28 UK NCRI Breast Clinical Studies Group Symptom management working party Members include: patient advocates nurses researchers oncologists psychologists statisticians molecular biologists physiologists gynaecologists complementary therapy specialists representatives from: Breast Cancer Care Breast Cancer Now (secretariat) Dr Adrienne Morgan
29 Working Party Symptom Management Initial Priority: Survey Patient & Healthcare perspectives Raise Awareness Educate Healthcare Professionals Hot Flush Surveys Breast Cancer Patients (n=666) Healthcare Professionals 1850 invited (n=185) GPs (n=79)
30 Do You Have Hot Flushes No: 3% Yes No Yes: 94%
31 GPs and HCPs significantly underestimate the impact of HF/NS on the lives of breast cancer patients % 6+ HF/NS 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% Don't know 65% of patients say that they have severe HF/NS BUT only 5% of GPs and HCPs thought that 65% of their patients have severe hot flushes. HCP GP
32 30% considered stopping endocrine therapy
33 Most believe that treatment of hot flushes in breast cancer patients is an unmet need Strongly agree Agree Disagree Strongly disagree HCP GPs 0.0% 20.0% 40.0% 60.0% 80.0% 100.0%
34 If you treat hot flushes medically what do you use? HRT Clonidine Paroxetine 14% 27% 36% 61% Venlafaxine Citalopram Gabapentin 37% HCP GP 77% Progesterone GPs prefer Clonidine and HCPs SSRIs Worrying level of HRT prescribed by GPs (27%)
35 Medical treatments not working for patients Menopause clinic Gabapentin SSRIs Clonidine Megace HRT Helped Suggested % 90% of professionals reported prescribing drugs to alleviate HFNS, BUT only 26% of the patients reported being offered drugs and fewer than 2% said they helped.
36 Managing hot flushes following breast cancer Author Date
37 Imperial College London Young Woman s Breast Cancer pathway
38
39 Model of multidisciplinary care: Menopause Symptoms After Cancer Clinic (MSAC)
40 New model of care for cancer patients with menopausal symptoms
41 Model of multidisciplinary care: Menopause Symptoms After Cancer Clinic (MSAC) Patient referred to MSAC Clinic Patient seen by menopause specialist Assessment Treatment plan Information Patient seen by nurse specialist Management Issues resolved by Multidisciplinary team Evidence-based Clinical guidelines Data collection Hickey et al 2008, 2010, Marino et al 2013, Marino et al 2014
42
43 Living with an Induced Menopause
44
45
46 Breast cancer No Age Treatment No Age Age (at diagnosis) surgery chemo radio hormone (42-84) 60 (38-82) 17 (85%) 8 (40%) 13 (65%) 12 (60%)
47 Gynaecological cancers No Age Type of cancer Treatment No Age Age (at diagnosis) Ovary/ tube/ peritoneum uterus cervix surgery chemo radio hormone (38-85) 58 (36-83) 27 (57%) 4 (9%) 12 (26%) 29 (62%) 38 (81%) 15 (32%) 5 (11%)
48 % Symptoms
49 Specialist menopause service
50 We need to clearly define referral pathways and delivery of care Increase awareness of existing menopause clinics Provide guidance approved by MDT with management issues resolved by MDT (Advisory group) Should we provide an MDT clinic? Menopause Symptoms After Cancer Clinic (MSAC)/Abernethy Train/Recruit a Clinical nurse specialist Pre-op (RRBSO) Include Haematological and other pelvic cancers Research agenda
51 Managing menopause after breast cancer Provide information about menopause and its management prior to chemotherapy No magic bullet Review the precipitating and exacerbating factors Prioritise: likely >1 symptom Individualise: Improving sleep can increase tolerance of daytime symptoms Consider multiple approaches Consider changing endocrine therapy Thomas et al Hickey et al 2008, 2010, 2014, Baum et al 2008
52 Thank UofGlasgow Search: University of Glasgow
Management of Menopausal Symptoms in Patients with Breast Cancer. Mike Dixon Edinburgh Breast Unit
Management of Menopausal Symptoms in Patients with Breast Cancer Mike Dixon Edinburgh Breast Unit Menopausal symptoms have a major impact on Quality of Life Variety of Symptoms associated with the Menopause
More informationNon hormonal medical treatment of vasomotor symptoms
Non hormonal medical treatment of vasomotor symptoms Caroline Antoine Menopause Clinic Department of Gynaecology and Obstetrics CHU Saint-Pierre Belgian Menopause Society Symposium November 14, 2015 No
More informationBackground History SSRIs for VMS
.pptx Non hormonal Pharmacologic Options: SSRIs/SNRIs/Gabapentin Susan D. Reed, MD, MPH Department of Obstetrics and Gynecology University of Washington, Seattle, WA Christopher Rasmussen, MD, InflaNATION
More informationLearning Objectives. Peri menopause. Menopause Overview. Recommendation grading categories
Learning Objectives Identify common symptoms of the menopause transition Understand the risks and benefits of hormone replacement therapy (HRT) Be able to choose an appropriate hormone replacement regimen
More informationMenopause management NICE Implementation
Menopause management NICE Implementation Dr Paula Briggs Consultant in Sexual & Reproductive Health Southport and Ormskirk NHS Hospital Trust Why a NICE guideline (NG 23) Media reports about HRT have not
More informationManaging menopause in Primary Care and recent advances in HRT
Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG PG Cert. Advanced Gynaecology Endoscopy Consultant Gynaecologist Heart of England NHS Foundation Trust Spire Parkway
More informationWHI Estrogen--Progestin vs. Placebo (Women with intact uterus)
HORMONE REPLACEMENT THERAPY In the historical period it was commonly held that estrogen had two principal benefits to postmenopausal women: 1) To alleviate the constitutional symptoms related to the climacteric
More informationPrimary Care of the Breast Cancer Survivor. Case Presentation. Case Presentation (cont) Case Presentation (cont) Breast Cancer
Primary Care of the Breast Cancer Survivor Janet P. Pregler, MD Professor of Clinical Medicine Director, Iris Cantor UCLA Women s Health Center Case Presentation B.C. is a 58 year-old African American
More informationPRESS RELEASE. NICE issues first guideline on menopause to stop women suffering in silence
EMBARGOED UNTIL: 00.01hrs, THURSDAY 12 NOVEMBER 2015 PRESS RELEASE NICE issues first guideline on menopause to stop women suffering in silence More than a million women could benefit from the first NICE
More informationBefore you prescribe
Initiating hormone replacement therapy (HRT) / menopausal hormone therapy (MHT) Dr Sonia Davison Jean Hailes Consultant Endocrinologist Before you prescribe Ensure there are no contraindications to HRT/MHT
More informationManagement of Menopausal Symptoms
Management of Menopausal Symptoms Tammie Koehler DO, FACOG 1 Menopause Permanent cessation of menstruation that occurs after the loss of ovarian activity Determined to have occurred after 1 full year of
More informationA Practitioner s Toolkit for the Management of the Menopause
Medicine, Nursing and Health Sciences A Practitioner s Toolkit for the Management of the Menopause Developed by the Women s Health Research Program School of Public Health and Preventive Medicine Monash
More informationLeslie R. Schover, PhD Department of Behavioral Science
Causes and Treatments of Low Sexual Desire in Breast Cancer Survivors Leslie R. Schover, PhD Department of Behavioral Science IMPORTANCE OF SEX TO BREAST CANCER SURVIVORS Livestrong 2006 Post-Treatment
More informationInterventions to Address Sexual Problems in People with Cancer
A Quality Initiative of the Program in Evidence-Based Care (PEBC), Cancer Care Ontario (CCO) Interventions to Address Sexual Problems in People with Cancer L. Barbera, C. Zwaal, D. Elterman, K. McPherson,
More informationMenopause: diagnosis and management NICE guideline NG23. Published November 2015
Menopause: diagnosis and management NICE guideline NG23 Published November 2015 1 Full title: Menopause : diagnosis and management Available at: http://www.nice.org.uk/guidance/ng23 Guideline published
More informationWomen s Health: Managing Menopause. Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School
Women s Health: Managing Menopause Jane S. Sillman, MD Assistant Professor of Medicine Harvard Medical School Disclosures I have no conflicts of interest. Learning Objectives 1. Apply strategies to help
More informationOVERVIEW OF MENOPAUSE
OVERVIEW OF MENOPAUSE Nicole Budrys, MD, MPH Reproductive Endocrinology Michigan Center for Fertility and Women s Health Presented at SEMCME March 13,2019 Objectives Define menopause Etiology of menopause
More informationCase Presentation. Learning Objectives. Case Presentation. Case Presentation
Learning Objectives To apply up to date information about the natural history of menopause to improve the care of individual women To counsel women about the risks and benefits of systemic hormone therapy
More informationIssues in Cancer Survivorship. Larissa A. Korde, MD, MPH June 26, 2010
Issues in Cancer Survivorship Larissa A. Korde, MD, MPH June 26, 2010 Estimated US Cancer Cases in Women: 2006-2008 CA Cancer J Clin 2006; 56:106-130; CA Cancer J Clin 2008;58:71 96. Relative Survival*
More informationMenopause & HRT. Matt McKenna Elliot Davis
Menopause & HRT Matt McKenna Elliot Davis Menopause Before age 40: Premature Menopause After 12 months clinical diagnosis made Depletion of Ovarian Follicles Oestrogen Progesterone LH FSH Spontaneous Amemorrhoea
More informationManaging menopause in Primary Care and recent advances in HRT
Managing menopause in Primary Care and recent advances in HRT Raj Saha, MD, DMRT, FRCOG Consultant Gynaecologist Heart of England NHS Foundation Trust rajsaha1@yahoo.co.uk Content of today s talk Aims
More information22/09/2014. Menopause Management. Menopause. Menopause symptoms
Menopause Management Dr Sonia Davison Jean Hailes for Women s Health Menopause Time of last menstrual period - average age 51 Premature Menopause: occurs before age 40 Perimenopause (menopause transition):
More informationPost-menopausal hormone replacement therapy. Evan Klass, MD May 17, 2018
Post-menopausal hormone replacement therapy Evan Klass, MD May 17, 2018 Are we really still talking about this? Are we really still talking about this? 1960-1975- estrogen prescriptions doubled. Pharma
More informationMenopause Symptoms and Management: After Breast Cancer
Menopause Symptoms and Management: After Breast Cancer An Educational Webinar for Patients and their Caregivers Wen Shen, MD, MPH Division of Gynecologic Specialties July 27, 2018 1 Disclosure I have a
More informationWhat is the menopause?
Information for you Alternatives to hormone replacement therapy for symptoms of the menopause Published in December 2011 This information is for you if you are considering alternatives to hormone replacement
More informationManagement of Perimenopausal symptoms
Management of Perimenopausal symptoms Serge Rozenberg CHU St Pierre Université libre de Bruxelles Belgium serge_rozenberg@stpierre-bru.be serge.rozenberg@skynet.be Conflict of interest & Disclosure Conflicts
More informationSouthern California Center for Sexual Health and Survivorship Medicine Inc, Newport Beach, CA 3
The WISDOM survey: Physicians Level of Comfort Prescribing Treatment for Vulvar and Vaginal Atrophy (VVA) Symptoms in Women with a Predisposition or History of Breast Cancer Lisa Larkin, MD 1 ; Michael
More informationA Non-Hormonal Approach to Preventing Vulvovaginal Atrophy from Aromatase Inhibitors (AIs)
A Non-Hormonal Approach to Preventing Vulvovaginal Atrophy from Aromatase Inhibitors (AIs) Leslie R. Schover, PhD Department of Behavioral Science Funded by the Duncan Family Institute for Cancer Prevention
More informationSleep in the Menopause Transition
Sleep in the Menopause Transition Hadine Joffe, MD, MSc Director, Women s Hormone & Aging Research Program www.brighamwharp.org Associate Professor, Harvard Medical School Vice Chair for Research & Director
More informationSurgery to Reduce the Risk of Ovarian Cancer. Information for Women at Increased Risk
Surgery to Reduce the Risk of Ovarian Cancer Information for Women at Increased Risk Centre for Genetics Education NSW Health 2017 The Centre for Genetics Education NSW Health Level 5 2C Herbert St St
More informationMENOPAUSE. I have no disclosures 10/11/18 OBJECTIVES WHAT S NEW? WHAT S SAFE?
MENOPAUSE WHAT S NEW? WHAT S SAFE? I have no disclosures Sara Whetstone, MD, MHS OBJECTIVES To describe risks of HT by age and menopause onset To recommend specific HT regimen for women who undergo early
More informationLong Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer
Global Breast Cancer Conference 2017 21 st Apr, 2017@Chezu Island Long Term Toxicity of Endocrine Therapy for premenopausal women with ER positive breast cancer Shinji Ohno, M.D., Ph.D., F.A.C.S. Breast
More informationHot flushes in breast cancer patients
Critical Reviews in Oncology/Hematology 57 (2006) 63 77 Hot flushes in breast cancer patients Constantijne H. Mom a, Ciska Buijs a, Pax H.B. Willemse a, Marian J.E. Mourits b, Elisabeth G.E. de Vries a,
More informationGP Education Series Women s cancers. GP Education Day 11 July 2016
GP Education Series Women s cancers GP Education Day 11 July 2016 Sexual Consequences of Treatment for Women s Cancers Dr Isabel White Clinical Research Fellow in Psychosexual Practice The Royal Marsden
More informationThis includes bone loss, endometrial cancer, and vasomotor symptoms.
Hello and welcome. My name is Chad Barnett. I m a Clinical Pharmacy Specialist in the Division of Pharmacy at the University of Texas, MD Anderson Cancer Center and I m very pleased today to be able to
More informationMenopause Matters. Equity Office Staff Seminar 14 November 2018
Menopause Matters Equity Office Staff Seminar 14 November 2018 1 What to expect at menopause How to manage symptoms Support at work Dr Janice Brown Medical lead, The University of Auckland NZ representative,
More informationMenopause and HRT. John Smiddy and Alistair Ledsam
Menopause and HRT John Smiddy and Alistair Ledsam Menopause The cessation of menstruation Diagnosed retrospectively after 1 year of amenorrhoea Average age 51 in the UK Normal physiology - Menstruation
More informationMENOPAUSAL HORMONE THERAPY 2016
MENOPAUSAL HORMONE THERAPY 2016 Carolyn J. Crandall, MD, MS Professor of Medicine David Geffen School of Medicine at UCLA NICE provides the National Health Service advice on effective, good value healthcare.
More informationPrior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD
Prior disclosures past 3 years Consultant for Pfizer University of Virginia received Grants/research support from TherapeuticsMD JoAnn V. Pinkerton, MD Professor of Obstetrics and Gynecology Director,
More information06-Mar-17. Premature menopause. Menopause. Premature menopause. Menstrual cycle oestradiol. Premature menopause. Prevalence ~1% Higher incidence:
Menopause Dr Sonia Davison MBBS FRACP PhD Endocrinologist and Clinical Fellow, Jean Hailes for Women s Health Women s Health Research Program, Monash University = the last natural menstrual period depletion
More informationCitation for published version (APA): Buijs, C. (2008). Long-term side effects of adjuvant breast cancer treatment s.n.
University of Groningen Long-term side effects of adjuvant breast cancer treatment Buijs, Ciska IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite
More informationMENOPAUSE / COMPLEX CONTRACEPTION / MEDICAL GYNAECOLOGY CLINICAL SERVICES AT CHALMERS
MENOPAUSE / COMPLEX CONTRACEPTION / MEDICAL GYNAECOLOGY CLINICAL SERVICES AT CHALMERS We welcome referrals of complex women and these should be for the attention of Dr Ailsa Gebbie. Details of receptor
More informationGabapentin to treat hot flashes
P ford residence southampton, ny Gabapentin to treat hot flashes 6-10-2010 An extendedrelease version of the seizure and pain drug gabapentin may be one step closer to becoming the first approved nonhormonal
More informationTreatment of Mood Disorders in Midlife Women
Treatment of Mood Disorders in Women KAY ROUSSOS-ROSS, MD UNIVERSITY OF FLORIDA DEPARTMENTS OF OBGYN AND PSYCHIATRY Disclosures I HAVE NO DISCLOSURES Objectives UNDERSTAND INCIDENCE OF MOOD DISORDERS IN
More informationThe Good, The Bad, and The Ugly of Hormonal Therapy, Trastuzumab and Docetaxel
The Good, The Bad, and The Ugly of Hormonal Therapy, Trastuzumab and Docetaxel Diane Johnson Pharmacist, CCMB June 6 th, 2015 Presenter Disclosure Speaker: Diane Johnson Relationships with commercial interests:
More informationYear: Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy
Year: 2013 - Issue 1 Obs/Gyne The silent epidemic: Postmenopausal vaginal atrophy By: Dr David W Sturdee, Immediate past President International Menopause Society and Hon Consultant Gynaecologist, Solihull
More informationOB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc.
OB/GYN Update: Menopausal Management What Does The Evidence Show? Rebecca Levy-Gantt D.O. PremierObGyn Napa Inc. Napa, California IMPORTANT SAFETY INFORMATION ABOUT EVAMIST: WARNING: ENDOMETRIAL CANCER,
More informationComplementary Therapy. Hormonal Treatment and Alternatives in Breast Cancer Survivors
Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer Complementary Therapy Hormonal Treatment and Alternatives in Breast Cancer Survivors Survivorship Complementary Therapy Hormonal
More information4 Call our Helpline on
Anastrozole This booklet explains what anastrozole is, how it works, when it may be prescribed, the benefits of taking it and the side effects you may experience. This information is by Breast Cancer
More informationVenlafaxine is superior to clonidine as treatment of hot flashes in breast cancer patients a double-blind, randomized study
Annals of Oncology 18: 689 693, 2007 doi:10.1093/annonc/mdl478 Published online 17 January 2007 is superior to as treatment of hot flashes in breast cancer patients a double-blind, randomized study S.
More informationReal life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study
Real life issues & answers: The hormonal patient Defining best practice, 5 key issues & case study Dr Louise Newson BSc(Hons) MBChB(Hons) MRCP FRCGP www.menopausedoctor.co.uk Case Number 1 - Claire Age
More informationCancer Genetics Unit Patient Information
Chemoprevention for women at an increased risk of familial breast cancer Cancer Genetics Unit Patient Information What is chemoprevention? Chemoprevention describes drugs that are used to reduce the risk
More informationSOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer
SOFTly: The Long Natural History of [Trials for] [premenopausal] ER+ Breast Cancer Charles Moertel Lecture May 12, 2017 Gini Fleming Charles Moertel Founder of NCCTG Dedication to high quality clinical
More informationNICE guideline Published: 12 November 2015 nice.org.uk/guidance/ng23
Menopause: diagnosis and management NICE guideline Published: 12 November 2015 nice.org.uk/guidance/ng23 NICE 2017. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
More informationEstrogen (conjugated estrogens & ethinyl estradiol) Addition to the List
Estrogen (conjugated estrogens & ethinyl estradiol) Addition to the List Note: Commonly prescribed medication. Literature question Is estrogen effective and safe? Are conjugated estrogens effective and
More informationInformation for you. Managing premenstrual syndrome (PMS) What is PMS?
Managing premenstrual syndrome (PMS) Information for you Published in August 2009 What is PMS? Premenstrual syndrome or PMS is the name given to a collection of physical and emotional symptoms that can
More informationHormonal Therapies for Breast Cancer. Westmead Breast Cancer Institute
Hormonal Therapies for Breast Cancer Westmead Breast Cancer Institute Hormonal (endocrine) therapies for breast cancer (also called anti-hormone treatment ) Hormonal therapy is used to treat breast cancers
More informationGary Elkins, PhD., ABPP
Gary Elkins, PhD., ABPP *What are Hot Flashes? *Hormone Replacement Therapy *Alternate Treatment Options *Clinical Hypnosis? *Methods *Preliminary Results *Conclusions & Future Directions *Over 66% of
More informationHRT & Menopause Where Do We Stand Now?
HRT & Menopause Where Do We Stand Now? Mrs. SY Hussain Consultant Gynaecologist The Holly Private Hospital Spire Roding Hospital The Wellington Hospital Discussion Points Discuss Recommendations made by
More information4 Call our Helpline on
Exemestane This booklet explains what exemestane is, how it works, when it may be prescribed, the benefits of taking it and the side effects you may experience. This information is by Breast Cancer Care.
More informationMenopause and Post Gynecological Reproductive Care
Menopause and Post Gynecological Reproductive Care Nguyet-Cam Vu Lam, MD, FAAFP Associate Program Director St. Luke s Family Medicine Residency 1 Disclosure Dr. Nguyet-Cam Vu Lam has no conflict of interest,
More informationMenopause & HRT. Rosie & Alex. Image:
Menopause & HRT Rosie & Alex Image: http://www.keepcalm-o-matic.co.uk/ Menopause The permanent cessation of menstruation for 12 months When does it happen? Average age 51 Image: Nature Medicine - 12, 612-613
More informationTreatment of Vasomotor Symptoms in a Transgender Male After Hysterectomy. Isabel Casimiro, MD PhD Endocrinology Fellow
Treatment of Vasomotor Symptoms in a Transgender Male After Hysterectomy Isabel Casimiro, MD PhD Endocrinology Fellow Disclosure Information I have the following financial relationships to disclose: Consultant
More informationDealing with menopausal symptoms in breast cancer patients
Dealing with menopausal symptoms in breast cancer patients Christian Egarter Prof, MD Head: Dept. Gyn. Endocrinology & Reproductive Medicine Medical University of Vienna Disclosure Gideon Richter: Speaker
More informationBy J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University
By J. Jayasutha Lecturer Department of Pharmacy Practice SRM College of Pharmacy SRM University Cessation of menstruation as a result of the aging process of or surgical removal of the ovaries; change
More informationSex, hormones and the heart
Sex, hormones and the heart Dr Louise Newson BSc(Hons) MBChB(Hons) MRCP FRCGP www.menopausedoctor.co.uk #IandA2017 Declaration I have had financial relationships (lecturer, writer, member of advisory boards
More informationBreast Cancer Treatment
Breast Cancer Treatment Treatment 2 aspects 1. Treatment of the breast itself: Local Treatment 2. Treatment of the whole body = Systemic treatment Local Treatment Surgery +/- Radiation Usually: a. Breast
More informationManaging premenstrual syndrome (PMS)
Information for you Published in March 2018 Managing premenstrual syndrome (PMS) About this information This information is for you if you have, or think you have, premenstrual syndrome (PMS) and want
More informationBreast Cancer Survivorship. Michelle Melisko MD Assistant Clinical Professor UCSF Breast Care Center
Breast Cancer Survivorship Michelle Melisko MD Assistant Clinical Professor UCSF Breast Care Center Survivors Who are they? An estimated 210,000 women were diagnosed with breast cancer in the year 2007
More informationMenopause After Breast Cancer. Westmead Breast Cancer Institute
Menopause After Breast Cancer Westmead Breast Cancer Institute What is menopause? Menopause is the time when menstrual periods stop. At menopause, the ovaries stop releasing eggs and producing oestrogen
More informationRegister No: Status: Public
MANAGEMENT OF MENOPAUSE CLINICAL GUIDELINES Register No: 18009 Status: Public Developed in response to: RCOG guideline: Best Practice 2015 Contributes to CQC 11, 12 Consulted With Post/Committee/Group
More informationPharmaceutical Interventions. Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007
Pharmaceutical Interventions Collaborative Model of Mental Health Care for Older Iowans Des Moines May 18, 2007 Outline Overview Overview of initial workup and decisions in elderly depressed individual
More informationHormone therapy. Where are we now? Menopause. Menopause symptoms. Background. Objective. Discussion. Keywords: menopause; hormone therapy
Menopause Helena J Teede Amanda Vincent Hormone therapy Where are we now? Background Menopause is the permanent cessation of menstruation resulting from loss of ovarian follicular activity. The characteristic
More informationPrescribing advice for the management of menopause in primary care
Prescribing advice for the management of menopause in primary care This guidance contains suggested advice for the management and treatment of women experiencing symptoms of menopause. It applies to Camden
More informationpresents with Ken Sekine, MD
presents Pioneering Technologies For Pellet Hormone Therapy Lifestyle Based Medicine A Primer for Clinicians with Ken Sekine, MD Dr. Sekine is a board certified OB-GYN who has been in private practice
More informationNavigating the Change: Leading Patients Through Menopause
4:30pm - 5:30pm: Breakout 5 - Women s Health Option A: Navigating the Change: Leading Patients Through Menopause ACPE UAN 0107-0000-10-025-L01-P 0.1 CEU/1.0 Hr. Activity Type: Application-Based Program
More informationNAMS in the News 2016
NAMS in the News 2016 Menopause in the News This is great support showing that being sedentary is not only not good for your health, it is not good for your menopause symptoms, said Dr. JoAnn Pinkerton,
More informationMenopause - a summary of management
Page 1 of 5 Menopause - a summary of management Original article by: May Su Resources Menopause treatment algorithm The Jean Hales Foundation for women's heath. Menopause, a treatment algorithm. (Australian
More informationAssessment and Treatment of Depression in Menopause
Disclosures Assessment and Treatment of Depression in Menopause Susan G. Kornstein, MD Professor of Psychiatry and Obstetrics-Gynecology Executive Director, Institute for Women s Health Virginia Commonwealth
More informationThis initial discovery led to the creation of two classes of first generation antidepressants:
Antidepressants - TCAs, MAOIs, SSRIs & SNRIs First generation antidepressants TCAs and MAOIs The discovery of antidepressants could be described as a lucky accident. During the 1950s, while carrying out
More information2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK
2017 Position Statement of Hormone Therapy of NAMS: overview SHELAGH LARSON, MS, RNC WHNP, NCMP ACCLAIM, JPS HEALTH NETWORK WHI the only large, long-term RCT of HT in women aged 50 to 79 years, Drug trail
More information11/15/2017. Update on HRT. Highgate Private Hospital (Barnet Hospital) Women s Health. Menopause
Update on HRT Miss Moneli Golara Consultant Obstetrician and Gynaecologist MBBS, FRCOG Highgate Private Hospital (Barnet Hospital) E: lauren@medicaladministration.co.uk Women s Health Life expectancy of
More informationInformation for you. Managing premenstrual syndrome (PMS) What is PMS?
Managing premenstrual syndrome (PMS) Information for you Published in August 2009 What is PMS? Premenstrual syndrome or PMS is the name given to a collection of physical and emotional symptoms that can
More informationFlashpoint: Regulating Your Body s Temperature. Presented by: Shari M. Lawson, MD MBA Date Presented: November 1,
Flashpoint: Regulating Your Body s Temperature Presented by: Shari M. Lawson, MD MBA Date Presented: November 1, 2014 1 Disclosures None 2 Objectives Today s discussion will cover How body temperature
More informationUpdate from the 25th Annual San Antonio Breast Cancer Symposium December 11 14, 2002
Update from the 25th Annual San Antonio Breast Cancer Symposium December 11 14, 2002 Nearly 5,000 physicians, oncologists, radiologists, epidemiologists, basic scientists, and breast cancer advocates from
More informationHORMONES AND YOUR HEALTH Charlie Tucker Pharm. D
HORMONES AND YOUR HEALTH Charlie Tucker Pharm. D All of the hormones in your body are designed to work together. This is God s plan. Therefore, if one is altered, or deficient, it will affect the actions
More informationFollow-up Care of Breast Cancer Patients
Follow-up Care of Breast Cancer Patients Dr. Simon D. Baxter, MD, FRCPC Medical Oncologist BC Cancer Kelowna Clinical Instructor, Dept of Medicine University of British Columbia 24 November 2018 Disclosures
More informationDisclosure statement
Menopause after cancer Dr Elizabeth Farrell AM MBBS, Hon LLD, FRCOG, FRACOG Gynaecologist & Medical Director Jean Hailes for Women s Health Disclosure statement Expert panel & consultant in last 5 years
More informationHormone therapy for menopausal vasomotor symptoms
Hormone therapy for menopausal vasomotor symptoms Given our available (better) options for treating hot flashes, can we reduce our use of medroxyprogesterone acetate? OBG Manag. 2014;26(7):10,13 15. Robert
More informationWestern Locality Shared care information ~ Gonadorelin Analogues (Gnrh)
Western Locality Shared care information ~ Gonadorelin Analogues (Gnrh) Specialist: Please complete the Shared Care letter sending a request to GP (see bottom of the page) April 2013 GP: Please indicate
More informationThe 6 th Scientific Meeting of the Asia Pacific Menopause Federation
Abnormal uterine bleeding in the perimenopause Perimenopausal menstrual problems are among the most common causes for family practitioner and specialist referral. Often it is due to the hormone changes
More informationGuidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)
MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive
More informationExemestane. This booklet explains what exemestane is, how it works, when it may be prescribed and possible side effects.
Exemestane This booklet explains what exemestane is, how it works, when it may be prescribed and possible side effects. This information is by Breast Cancer Care. We are the only specialist UK-wide charity
More informationHow is primary breast cancer treated? This booklet is for anyone who has primary breast cancer and wants to know more about how it is treated.
How is primary breast cancer treated? This booklet is for anyone who has primary breast cancer and wants to know more about how it is treated. How is primary breast cancer treated? Part 1 the treatment
More informationMenopausal Symptoms. Hormone Therapy Products Available in Canada for the Treatment of. Physician Desk Reference - 3rd Edition
Hormone Therapy Products Available in Canada for the Treatment of Menopausal Symptoms Physician Desk Reference - 3rd Edition A clinical resource provided to you by: The Society of Obstetricians and Gynaecologists
More informationAusPharm CE Hormone therapy 23/09/10. Hormone therapy
Hormone therapy Learning objectives: Assess options to address quality of life and health concerns of menopausal women Outline indications for hormone therapy Counsel women on the risks and benefits of
More informationBreast Cancer Treatments Breast surgery either breast conserving lumpectomy or modified mastectomy. May also include immediate or delayed reconstructi
The Gynecologic Implications of Breast Cancer Mindy Goldman, MD Clinical Professor Dept. of OB/Gyn and Reproductive Sciences Director, Women s Cancer Care Program, Carol Franc Buck Breast Care Center and
More information